Clinical Trial Update: An Observational, Multicenter Study Evaluating the Safety of ReAl-lifePertuzumab and Trastuzumab Fixed Dose Combination: the RAPID Study

View source ↗

Summary

A completed observational multicenter study evaluating the safety of a real-world fixed-dose combination of pertuzumab and trastuzumab in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)

Snippet

Sponsor: Fondazione Oncotech | Conditions: Breast Cancer | Status: COMPLETED